Kezar Life Sciences, Inc. (KZR) with an increase of 10%; highlighted data from the Phase 1b portion of the MISSION study displaying safety, acceptability and early effectiveness signals of KZR-616 in patients with systemic lupus erythematosus and lupus nephritis at the Pan-American Congress of Rheumatology.

Adamis Pharmaceuticals Corporation (ADMP) with a decrease of 7.6%; today revealed that it plans to offer to sell shares of its common stock in an underwritten public offering. The corporation expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 15% of the number of shares of common stock provided in the public offering.

Essential Properties Realty Trust, Inc (EPRT) with a decrease of 3.2%; initiated an underwritten public offering of 8,000,000 shares of its common stock. The Corporation expects to grant the underwriters a 30-day option to obtain up to a further 1,200,000 shares of common stock.